Global Omega-3 Polyunsaturated Fatty Acid Market Research and Analysis, 2015-2021
MARKET INSIGHTS:
Global Omega-3 Polyunsaturated Fatty Acid Market is expected to grow at a CAGR 8.2% during the forecasted period from 2016-2021. Global Omega-3 Polyunsaturated Fatty Acid Market is growing at a modest rate due to huge consumption omega-3 in dietary supplements and pharmaceuticals across the globe. Omega-3 Fatty Acids cannot be synthesized by human body and it is considered to be essential element to enhance the metabolic activities such as Cognitive and Cardiovascular functions. As a result the adoption of omega-3 is rising through rising awareness and easy availability of omega-3 fatty acids in market. Global rise in life style oriented diseases such as CVD, CHD, Rheumatic Arthritis, Parkinson’s disease and other lingering diseases are boosting the global omega-3 PUFA Market.
Omega-3 Polyunsaturated Fatty Acids Market By application such as functional food & beverages, pharmaceuticals, infant formula, dietary supplements and so on are widely adopted across the globe. Omega-3 fatty acids are polyunsaturated fatty acids and have various health benefits and are essential for improving metabolic rate and fulfill the requirement of essential nutrients in human body. Omega-3 PUFA has been a key ingredient in the pharmaceuticals market and widely adopted in capsules, oils and functional foods across the globe. R&D is driving the Global Omega-3 Polyunsaturated Fatty Acid Market and enable the market to grow extensively.
Omega-3 has huge demand in functional food & beverage market to produce products such as nutritive drinks, health supplements and medical drugs. Global Omega-3 PUFA Market is growing at a modest rate due to rising demand from nutrition industry for health supplements and healthcare industry for infant mental health and development. Pharmaceutical drug manufacturers are using Omega-3 as an ingredient in drugs which are used to treat various life style oriented diseases. Rise in health consciousness among individuals and wide variety of Omega-3 products are expected to drive the market in near future.
The Global Omega-3 Polyunsaturated Fatty Acid Market is affected by the high cost due to low production of fish oil and huge expenditure in R&D. However, rising alternatives of omega-3 through marine and plant sources are expected to overcome the high cost. The report also includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.
GEOGRAPHICAL INSIGHTS:
North America and Europe has the highest contribution to Global Omega-3 Polyunsaturated Fatty Acid market followed by Europe. Global Omega-3 Polyunsaturated Fatty Acid Market is growing considerably in North America and Europe due to huge consumption of omega-3 for health benefits and fitness. Europe and North America have the highest consumption of Omega-3 through dietary supplement, functional food & beverages. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create considerable opportunities due to huge customer base and rising awareness for health benefits. APAC region is considered to be lucrative for Global Omega-3 Polyunsaturated Fatty Acid Market due to huge population, improved healthcare spending and rising awareness.
COMPETITIVE INSIGHTS:
The key players of Global Omega-3 Polyunsaturated Fatty Acid Market includes: Aker Bio Marine ASA, Clover Corporation, Copenica ASA, Croda International Plc., Denemoga, FMC Corporation, GC Rieber, Golden Omega S.A., KD Pharma Bexbach Gmbh, Marine Ingredients Llc., Omega Protein Corporation, Orkla ASA, Pharma Marine Llc., Polaris, Pronovabiopharma ASA, Royal DSM N.V., Tasa Omega. Various corporate strategies such as R&D, product launch, partnership and collaboration are widely adopted by key players to stay competitive.
MARKET SEGMENTATION:
Global Omega-3 Polyunsaturated Fatty Acid Market is segmented on the basis of Type, Application and Region. Global Omega-3 Polyunsaturated Fatty Acid Market by Type includes Docosahexaenoic Acid, Eicosapentaenoic Acid & Alpha-Linolenic Acid Market. Global Omega-3 Polyunsaturated Fatty Acid Market by Application includes Alpha-Linolenic Acid, Functional Foods & Beverages, Pharmaceuticals,
Global Omega-3 Polyunsaturated Fatty Acid Market is expected to grow at a CAGR 8.2% during the forecasted period from 2016-2021. Global Omega-3 Polyunsaturated Fatty Acid Market is growing at a modest rate due to huge consumption omega-3 in dietary supplements and pharmaceuticals across the globe. Omega-3 Fatty Acids cannot be synthesized by human body and it is considered to be essential element to enhance the metabolic activities such as Cognitive and Cardiovascular functions. As a result the adoption of omega-3 is rising through rising awareness and easy availability of omega-3 fatty acids in market. Global rise in life style oriented diseases such as CVD, CHD, Rheumatic Arthritis, Parkinson’s disease and other lingering diseases are boosting the global omega-3 PUFA Market.
Omega-3 Polyunsaturated Fatty Acids Market By application such as functional food & beverages, pharmaceuticals, infant formula, dietary supplements and so on are widely adopted across the globe. Omega-3 fatty acids are polyunsaturated fatty acids and have various health benefits and are essential for improving metabolic rate and fulfill the requirement of essential nutrients in human body. Omega-3 PUFA has been a key ingredient in the pharmaceuticals market and widely adopted in capsules, oils and functional foods across the globe. R&D is driving the Global Omega-3 Polyunsaturated Fatty Acid Market and enable the market to grow extensively.
Omega-3 has huge demand in functional food & beverage market to produce products such as nutritive drinks, health supplements and medical drugs. Global Omega-3 PUFA Market is growing at a modest rate due to rising demand from nutrition industry for health supplements and healthcare industry for infant mental health and development. Pharmaceutical drug manufacturers are using Omega-3 as an ingredient in drugs which are used to treat various life style oriented diseases. Rise in health consciousness among individuals and wide variety of Omega-3 products are expected to drive the market in near future.
The Global Omega-3 Polyunsaturated Fatty Acid Market is affected by the high cost due to low production of fish oil and huge expenditure in R&D. However, rising alternatives of omega-3 through marine and plant sources are expected to overcome the high cost. The report also includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.
GEOGRAPHICAL INSIGHTS:
North America and Europe has the highest contribution to Global Omega-3 Polyunsaturated Fatty Acid market followed by Europe. Global Omega-3 Polyunsaturated Fatty Acid Market is growing considerably in North America and Europe due to huge consumption of omega-3 for health benefits and fitness. Europe and North America have the highest consumption of Omega-3 through dietary supplement, functional food & beverages. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create considerable opportunities due to huge customer base and rising awareness for health benefits. APAC region is considered to be lucrative for Global Omega-3 Polyunsaturated Fatty Acid Market due to huge population, improved healthcare spending and rising awareness.
COMPETITIVE INSIGHTS:
The key players of Global Omega-3 Polyunsaturated Fatty Acid Market includes: Aker Bio Marine ASA, Clover Corporation, Copenica ASA, Croda International Plc., Denemoga, FMC Corporation, GC Rieber, Golden Omega S.A., KD Pharma Bexbach Gmbh, Marine Ingredients Llc., Omega Protein Corporation, Orkla ASA, Pharma Marine Llc., Polaris, Pronovabiopharma ASA, Royal DSM N.V., Tasa Omega. Various corporate strategies such as R&D, product launch, partnership and collaboration are widely adopted by key players to stay competitive.
MARKET SEGMENTATION:
Global Omega-3 Polyunsaturated Fatty Acid Market is segmented on the basis of Type, Application and Region. Global Omega-3 Polyunsaturated Fatty Acid Market by Type includes Docosahexaenoic Acid, Eicosapentaenoic Acid & Alpha-Linolenic Acid Market. Global Omega-3 Polyunsaturated Fatty Acid Market by Application includes Alpha-Linolenic Acid, Functional Foods & Beverages, Pharmaceuticals,
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PORTER’S FIVE FORCES ANALYSIS
2.6. PESTLE ANALYSIS
2.7. ANALYST INSIGHT
2.7.1. KEY FINDINGS
2.7.2. RECOMMENDATION
2.7.3. CONCLUSION
2.8. REGULATION
2.8.1. REGULATIONS ON TAX POLICIES
2.8.1.1. UNITED STATES
2.8.1.2. EUROPEAN UNION
2.8.1.3. CHINA
2.8.1.4. INDIA
2.8.1.5. REST OF THE WORLD
2.8.2. GOVERNMENT POLICIES
2.8.2.1. UNITED STATES
2.8.2.2. EUROPEAN UNION
2.8.2.3. CHINA
2.8.2.4. INDIA
2.8.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF OMEGA-3 FOR HEALTH BENEFITS
3.1.2. RISING CONSUMER AWARENESS FOR OMEGA-3
3.1.3. RISE IN ADOPTION OF OMEGA-3 IN FUNCTIONAL FOODS & PHARMACEUTICAL INDUSTRIES
3.1.4. TECHNOLOGICAL ADVANCEMENT INCREASED THE EFFICIENCY & PRODUCTION OF OMEGA-3 POLYUNSATURATED MARKET
3.1.5. RESEARCH & DEVELOPMENT TO DRIVE THE GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET
3.1.6. RISE IN LIFE STYLE ORIENTED DISEASES TO BOOST THE GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET PRODUCTS DUE TO LOW PRODUCTION OF FISH OIL
3.2.2. HUGE INVESTMENT IN R&D PROCESS
3.3. OPPORTUNITY
3.3.1. AVAILABILITY OF ALTERNATES TO OBTAIN OMEGA-3 POLYUNSATURATED ACID WILL BOOST THE MARKET
3.3.2. UNTAPPED APAC REGION IS FULL OF OPPORTUNITY FOR GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET
MARKET SEGMENTATION
4.1. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021, ($ MILLIONS)
4.1.1. GLOBAL DIETARY SUPPLEMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2. GLOBAL FUNCTIONAL FOODS & BEVERAGES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3. GLOBAL PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4. GLOBAL INFANT FORMULA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.5. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY SOURCE & SUB-SOURCE, 2015-2021, ($ MILLIONS)
4.2.1. GLOBAL MARINE SOURCES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.1. GLOBAL FISH OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.2. GLOBAL ALGAL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.3. GLOBAL KRILL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.4. GLOBAL HEMP OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.5. GLOBAL OTHER MARINE OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2. GLOBAL PLANT SOURCE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.1. GLOBAL FLAXSEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.2. GLOBAL CHIA SEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.3. GLOBAL OTHER PLANT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
4.3.1. GLOBAL DOCOSAHEXAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.2. GLOBAL EICOSAPENTAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.3. GLOBAL ALPHA-LINOLENIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. AKER BIO MARINE ASA
7.1.1. INTRODUCTION
7.1.2. AKER BIO MARINE ASA PRODUCT PORTFOLIO
7.1.3. AKER BIO MARINE ASA RECENT ACTIVITIES
7.1.4. AKER BIO MARINE ASA SWOT ANALYSIS
7.2. ARISTA INDUSTRIES INC.
7.2.1. INTRODUCTION
7.2.2. ARISTA INDUSTRIES INC. PRODUCT PORTFOLIO
7.2.3. ARISTA INDUSTRIES INC. RECENT ACTIVITIES
7.2.4. ARISTA INDUSTRIES INC. SWOT ANALYSIS
7.3. BASF
7.3.1. INTRODUCTION
7.3.2. BASF PRODUCT PORTFOLIO
7.3.3. BASF RECENT ACTIVITIES
7.3.4. BASF SWOT ANALYSIS
7.4. CARGILL, INCORPORATED
7.4.1. INTRODUCTION
7.4.2. CARGILL, INCORPORATED PRODUCT PORTFOLIO
7.4.3. CARGILL, INCORPORATED RECENT ACTIVITIES
7.4.4. CARGILL, INCORPORATED SWOT ANALYSIS
7.5. CLOVER CORPORATION
7.5.1. INTRODUCTION
7.5.2. CLOVER CORPORATION PRODUCT PORTFOLIO
7.5.3. CLOVER CORPORATION RECENT ACTIVITIES
7.5.4. CLOVER CORPORATION SWOT ANALYSIS
7.6. COPENICA ASA
7.6.1. INTRODUCTION
7.6.2. COPENICA ASA PRODUCT PORTFOLIO
7.6.3. COPENICA ASA RECENT ACTIVITIES
7.6.4. COPENICA ASA SWOT ANALYSIS
7.7. CRODA INTERNATIONAL PLC
7.7.1. INTRODUCTION
7.7.2. CRODA INTERNATIONAL PLC PRODUCT PORTFOLIO
7.7.3. CRODA INTERNATIONAL PLC RECENT ACTIVITIES
7.7.4. CRODA INTERNATIONAL PLC SWOT ANALYSIS
7.8. DENEMOGA
7.8.1. INTRODUCTION
7.8.2. DENEMOGA PRODUCT PORTFOLIO
7.8.3. DENEMOGA RECENT ACTIVITIES
7.8.4. DENEMOGA SWOT ANALYSIS
7.9. FMC CORPORATION
7.9.1. INTRODUCTION
7.9.2. FMC CORPORATION PRODUCT PORTFOLIO
7.9.3. FMC CORPORATION RECENT ACTIVITIES
7.9.4. FMC CORPORATION SWOT ANALYSIS
7.10. GC RIEBER
7.10.1. INTRODUCTION
7.10.2. GC RIEBER PRODUCT PORTFOLIO
7.10.3. GC RIEBER RECENT ACTIVITIES
7.10.4. GC RIEBER SWOT ANALYSIS
7.11. GOLDEN OMEGA S.A.
7.11.1. INTRODUCTION
7.11.2. GOLDEN OMEGA S.A. PRODUCT PORTFOLIO
7.11.3. GOLDEN OMEGA S.A. RECENT ACTIVITIES
7.11.4. GOLDEN OMEGA S.A. SWOT ANALYSIS
7.12. KD PHARMA BEXBACH GMBH
7.12.1. INTRODUCTION
7.12.2. KD PHARMA BEXBACH GMBH PRODUCT PORTFOLIO
7.12.3. KD PHARMA BEXBACH GMBH RECENT ACTIVITIES
7.12.4. KD PHARMA BEXBACH GMBH SWOT ANALYSIS
7.13. MARINE INGREDIENTS LLC.
7.13.1. INTRODUCTION
7.13.2. MARINE INGREDIENTS LLC. PRODUCT PORTFOLIO
7.13.3. MARINE INGREDIENTS LLC. RECENT ACTIVITIES
7.13.4. MARINE INGREDIENTS LLC. SWOT ANALYSIS
7.14. OMEGA PROTEIN CORPORATION
7.14.1. INTRODUCTION
7.14.2. OMEGA PROTEIN CORPORATION PRODUCT PORTFOLIO
7.14.3. OMEGA PROTEIN CORPORATION RECENT ACTIVITIES
7.14.4. OMEGA PROTEIN CORPORATION SWOT ANALYSIS
7.15. ORKLA ASA
7.15.1. INTRODUCTION
7.15.2. ORKLA ASA PRODUCT PORTFOLIO
7.15.3. ORKLA ASA RECENT ACTIVITIES
7.15.4. ORKLA ASA SWOT ANALYSIS
7.16. PHARMA MARINE USA LLC
7.16.1. INTRODUCTION
7.16.2. PHARMA MARINE USA LLC PRODUCT PORTFOLIO
7.16.3. PHARMA MARINE USA LLC RECENT ACTIVITIES
7.16.4. PHARMA MARINE USA LLC SWOT ANALYSIS
7.17. POLARIS
7.17.1. INTRODUCTION
7.17.2. POLARIS PRODUCT PORTFOLIO
7.17.3. POLARIS RECENT ACTIVITIES
7.17.4. POLARIS SWOT ANALYSIS
7.18. PRONOVABIOPHARMA ASA
7.18.1. INTRODUCTION
7.18.2. PRONOVABIOPHARMA ASA PRODUCT PORTFOLIO
7.18.3. PRONOVABIOPHARMA ASA RECENT ACTIVITIES
7.18.4. PRONOVABIOPHARMA ASA SWOT ANALYSIS
7.19. ROYAL DSM N.V.
7.19.1. INTRODUCTION
7.19.2. ROYAL DSM N.V. PRODUCT PORTFOLIO
7.19.3. ROYAL DSM N.V. RECENT ACTIVITIES
7.19.4. ROYAL DSM N.V. SWOT ANALYSIS
7.20. TASA OMEGA
7.20.1. INTRODUCTION
7.20.2. TASA OMEGA PRODUCT PORTFOLIO
7.20.3. TASA OMEGA RECENT ACTIVITIES
7.20.4. TASA OMEGA SWOT ANALYSIS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PORTER’S FIVE FORCES ANALYSIS
2.6. PESTLE ANALYSIS
2.7. ANALYST INSIGHT
2.7.1. KEY FINDINGS
2.7.2. RECOMMENDATION
2.7.3. CONCLUSION
2.8. REGULATION
2.8.1. REGULATIONS ON TAX POLICIES
2.8.1.1. UNITED STATES
2.8.1.2. EUROPEAN UNION
2.8.1.3. CHINA
2.8.1.4. INDIA
2.8.1.5. REST OF THE WORLD
2.8.2. GOVERNMENT POLICIES
2.8.2.1. UNITED STATES
2.8.2.2. EUROPEAN UNION
2.8.2.3. CHINA
2.8.2.4. INDIA
2.8.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF OMEGA-3 FOR HEALTH BENEFITS
3.1.2. RISING CONSUMER AWARENESS FOR OMEGA-3
3.1.3. RISE IN ADOPTION OF OMEGA-3 IN FUNCTIONAL FOODS & PHARMACEUTICAL INDUSTRIES
3.1.4. TECHNOLOGICAL ADVANCEMENT INCREASED THE EFFICIENCY & PRODUCTION OF OMEGA-3 POLYUNSATURATED MARKET
3.1.5. RESEARCH & DEVELOPMENT TO DRIVE THE GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET
3.1.6. RISE IN LIFE STYLE ORIENTED DISEASES TO BOOST THE GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF GLOBAL OMEGA-3 UNSATURATED FATTY ACID MARKET PRODUCTS DUE TO LOW PRODUCTION OF FISH OIL
3.2.2. HUGE INVESTMENT IN R&D PROCESS
3.3. OPPORTUNITY
3.3.1. AVAILABILITY OF ALTERNATES TO OBTAIN OMEGA-3 POLYUNSATURATED ACID WILL BOOST THE MARKET
3.3.2. UNTAPPED APAC REGION IS FULL OF OPPORTUNITY FOR GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET
MARKET SEGMENTATION
4.1. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021, ($ MILLIONS)
4.1.1. GLOBAL DIETARY SUPPLEMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2. GLOBAL FUNCTIONAL FOODS & BEVERAGES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3. GLOBAL PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4. GLOBAL INFANT FORMULA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.5. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY SOURCE & SUB-SOURCE, 2015-2021, ($ MILLIONS)
4.2.1. GLOBAL MARINE SOURCES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.1. GLOBAL FISH OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.2. GLOBAL ALGAL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.3. GLOBAL KRILL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.4. GLOBAL HEMP OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.1.5. GLOBAL OTHER MARINE OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2. GLOBAL PLANT SOURCE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.1. GLOBAL FLAXSEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.2. GLOBAL CHIA SEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2.3. GLOBAL OTHER PLANT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3. GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
4.3.1. GLOBAL DOCOSAHEXAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.2. GLOBAL EICOSAPENTAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.3. GLOBAL ALPHA-LINOLENIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. AKER BIO MARINE ASA
7.1.1. INTRODUCTION
7.1.2. AKER BIO MARINE ASA PRODUCT PORTFOLIO
7.1.3. AKER BIO MARINE ASA RECENT ACTIVITIES
7.1.4. AKER BIO MARINE ASA SWOT ANALYSIS
7.2. ARISTA INDUSTRIES INC.
7.2.1. INTRODUCTION
7.2.2. ARISTA INDUSTRIES INC. PRODUCT PORTFOLIO
7.2.3. ARISTA INDUSTRIES INC. RECENT ACTIVITIES
7.2.4. ARISTA INDUSTRIES INC. SWOT ANALYSIS
7.3. BASF
7.3.1. INTRODUCTION
7.3.2. BASF PRODUCT PORTFOLIO
7.3.3. BASF RECENT ACTIVITIES
7.3.4. BASF SWOT ANALYSIS
7.4. CARGILL, INCORPORATED
7.4.1. INTRODUCTION
7.4.2. CARGILL, INCORPORATED PRODUCT PORTFOLIO
7.4.3. CARGILL, INCORPORATED RECENT ACTIVITIES
7.4.4. CARGILL, INCORPORATED SWOT ANALYSIS
7.5. CLOVER CORPORATION
7.5.1. INTRODUCTION
7.5.2. CLOVER CORPORATION PRODUCT PORTFOLIO
7.5.3. CLOVER CORPORATION RECENT ACTIVITIES
7.5.4. CLOVER CORPORATION SWOT ANALYSIS
7.6. COPENICA ASA
7.6.1. INTRODUCTION
7.6.2. COPENICA ASA PRODUCT PORTFOLIO
7.6.3. COPENICA ASA RECENT ACTIVITIES
7.6.4. COPENICA ASA SWOT ANALYSIS
7.7. CRODA INTERNATIONAL PLC
7.7.1. INTRODUCTION
7.7.2. CRODA INTERNATIONAL PLC PRODUCT PORTFOLIO
7.7.3. CRODA INTERNATIONAL PLC RECENT ACTIVITIES
7.7.4. CRODA INTERNATIONAL PLC SWOT ANALYSIS
7.8. DENEMOGA
7.8.1. INTRODUCTION
7.8.2. DENEMOGA PRODUCT PORTFOLIO
7.8.3. DENEMOGA RECENT ACTIVITIES
7.8.4. DENEMOGA SWOT ANALYSIS
7.9. FMC CORPORATION
7.9.1. INTRODUCTION
7.9.2. FMC CORPORATION PRODUCT PORTFOLIO
7.9.3. FMC CORPORATION RECENT ACTIVITIES
7.9.4. FMC CORPORATION SWOT ANALYSIS
7.10. GC RIEBER
7.10.1. INTRODUCTION
7.10.2. GC RIEBER PRODUCT PORTFOLIO
7.10.3. GC RIEBER RECENT ACTIVITIES
7.10.4. GC RIEBER SWOT ANALYSIS
7.11. GOLDEN OMEGA S.A.
7.11.1. INTRODUCTION
7.11.2. GOLDEN OMEGA S.A. PRODUCT PORTFOLIO
7.11.3. GOLDEN OMEGA S.A. RECENT ACTIVITIES
7.11.4. GOLDEN OMEGA S.A. SWOT ANALYSIS
7.12. KD PHARMA BEXBACH GMBH
7.12.1. INTRODUCTION
7.12.2. KD PHARMA BEXBACH GMBH PRODUCT PORTFOLIO
7.12.3. KD PHARMA BEXBACH GMBH RECENT ACTIVITIES
7.12.4. KD PHARMA BEXBACH GMBH SWOT ANALYSIS
7.13. MARINE INGREDIENTS LLC.
7.13.1. INTRODUCTION
7.13.2. MARINE INGREDIENTS LLC. PRODUCT PORTFOLIO
7.13.3. MARINE INGREDIENTS LLC. RECENT ACTIVITIES
7.13.4. MARINE INGREDIENTS LLC. SWOT ANALYSIS
7.14. OMEGA PROTEIN CORPORATION
7.14.1. INTRODUCTION
7.14.2. OMEGA PROTEIN CORPORATION PRODUCT PORTFOLIO
7.14.3. OMEGA PROTEIN CORPORATION RECENT ACTIVITIES
7.14.4. OMEGA PROTEIN CORPORATION SWOT ANALYSIS
7.15. ORKLA ASA
7.15.1. INTRODUCTION
7.15.2. ORKLA ASA PRODUCT PORTFOLIO
7.15.3. ORKLA ASA RECENT ACTIVITIES
7.15.4. ORKLA ASA SWOT ANALYSIS
7.16. PHARMA MARINE USA LLC
7.16.1. INTRODUCTION
7.16.2. PHARMA MARINE USA LLC PRODUCT PORTFOLIO
7.16.3. PHARMA MARINE USA LLC RECENT ACTIVITIES
7.16.4. PHARMA MARINE USA LLC SWOT ANALYSIS
7.17. POLARIS
7.17.1. INTRODUCTION
7.17.2. POLARIS PRODUCT PORTFOLIO
7.17.3. POLARIS RECENT ACTIVITIES
7.17.4. POLARIS SWOT ANALYSIS
7.18. PRONOVABIOPHARMA ASA
7.18.1. INTRODUCTION
7.18.2. PRONOVABIOPHARMA ASA PRODUCT PORTFOLIO
7.18.3. PRONOVABIOPHARMA ASA RECENT ACTIVITIES
7.18.4. PRONOVABIOPHARMA ASA SWOT ANALYSIS
7.19. ROYAL DSM N.V.
7.19.1. INTRODUCTION
7.19.2. ROYAL DSM N.V. PRODUCT PORTFOLIO
7.19.3. ROYAL DSM N.V. RECENT ACTIVITIES
7.19.4. ROYAL DSM N.V. SWOT ANALYSIS
7.20. TASA OMEGA
7.20.1. INTRODUCTION
7.20.2. TASA OMEGA PRODUCT PORTFOLIO
7.20.3. TASA OMEGA RECENT ACTIVITIES
7.20.4. TASA OMEGA SWOT ANALYSIS
LIST OF TABLES
TABLE # 1 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL HOMOGENIZERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL DIETARY SUPPLEMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL FUNCTIONAL FOODS & BEVERAGES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL INFANT FORMULA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY SOURCE & SUB-SOURCE, 2015-2021, ($ MILLIONS)
TABLE # 10 GLOBAL MARINE SOURCES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 11 GLOBAL FISH OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 12 GLOBAL ALGAL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 13 GLOBAL KRILL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 14 GLOBAL HEMP OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 15 GLOBAL OTHER MARINE OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 16 GLOBAL PLANT SOURCE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 17 GLOBAL FLAXSEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 18 GLOBAL CHIA SEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 19 GLOBAL OTHER PLANT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 20 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 21 GLOBAL DOCOSAHEXAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 22 GLOBAL EICOSAPENTAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 23 GLOBAL ALPHA-LINOLENIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 24 AKER BIO MARINE ASA PRODUCT PORTFOLIO
TABLE # 25 AKER BIO MARINE ASA RECENT ACTIVITIES
TABLE # 26 AKER BIO MARINE ASA SWOT ANALYSIS
TABLE # 27 ARISTA INDUSTRIES INC. PRODUCT PORTFOLIO
TABLE # 28 ARISTA INDUSTRIES INC. RECENT ACTIVITIES
TABLE # 29 ARISTA INDUSTRIES INC. SWOT ANALYSIS
TABLE # 30 BASF PRODUCT PORTFOLIO
TABLE # 31 BASF RECENT ACTIVITIES
TABLE # 32 BASF SWOT ANALYSIS
TABLE # 33 CARGILL, INCORPORATED PRODUCT PORTFOLIO
TABLE # 34 CARGILL, INCORPORATED RECENT ACTIVITIES
TABLE # 35 CARGILL, INCORPORATED SWOT ANALYSIS
TABLE # 36 CLOVER CORPORATION PRODUCT PORTFOLIO
TABLE # 37 CLOVER CORPORATION RECENT ACTIVITIES
TABLE # 38 CLOVER CORPORATION SWOT ANALYSIS
TABLE # 39 COPENICA ASA PRODUCT PORTFOLIO
TABLE # 40 COPENICA ASA RECENT ACTIVITIES
TABLE # 41 COPENICA ASA SWOT ANALYSIS
TABLE # 42 CRODA INTERNATIONAL PLC PRODUCT PORTFOLIO
TABLE # 43 CRODA INTERNATIONAL PLC RECENT ACTIVITIES
TABLE # 44 CRODA INTERNATIONAL PLC SWOT ANALYSIS
TABLE # 45 DENEMOGA PRODUCT PORTFOLIO
TABLE # 46 DENEMOGA RECENT ACTIVITIES
TABLE # 47 DENEMOGA SWOT ANALYSIS
TABLE # 48 FMC CORPORATION PRODUCT PORTFOLIO
TABLE # 49 FMC CORPORATION RECENT ACTIVITIES
TABLE # 50 FMC CORPORATION SWOT ANALYSIS
TABLE # 51 GC RIEBER PRODUCT PORTFOLIO
TABLE # 52 GC RIEBER RECENT ACTIVITIES
TABLE # 53 GC RIEBER SWOT ANALYSIS
TABLE # 54 GOLDEN OMEGA S.A. PRODUCT PORTFOLIO
TABLE # 55 GOLDEN OMEGA S.A. RECENT ACTIVITIES
TABLE # 56 GOLDEN OMEGA S.A. SWOT ANALYSIS
TABLE # 57 KD PHARMA BEXBACH GMBH PRODUCT PORTFOLIO
TABLE # 58 KD PHARMA BEXBACH GMBH RECENT ACTIVITIES
TABLE # 59 KD PHARMA BEXBACH GMBH SWOT ANALYSIS
TABLE # 60 MARINE INGREDIENTS LLC. PRODUCT PORTFOLIO
TABLE # 61 MARINE INGREDIENTS LLC. RECENT ACTIVITIES
TABLE # 62 MARINE INGREDIENTS LLC. SWOT ANALYSIS
TABLE # 63 OMEGA PROTEIN CORPORATION PRODUCT PORTFOLIO
TABLE # 64 OMEGA PROTEIN CORPORATION RECENT ACTIVITIES
TABLE # 65 OMEGA PROTEIN CORPORATION SWOT ANALYSIS
TABLE # 66 ORKLA ASA PRODUCT PORTFOLIO
TABLE # 67 ORKLA ASA RECENT ACTIVITIES
TABLE # 68 ORKLA ASA SWOT ANALYSIS
TABLE # 69 PHARMA MARINE USA LLC PRODUCT PORTFOLIO
TABLE # 70 PHARMA MARINE USA LLC RECENT ACTIVITIES
TABLE # 71 PHARMA MARINE USA LLC SWOT ANALYSIS
TABLE # 72 POLARIS PRODUCT PORTFOLIO
TABLE # 73 POLARIS RECENT ACTIVITIES
TABLE # 74 POLARIS SWOT ANALYSIS
TABLE # 75 PRONOVABIOPHARMA ASA PRODUCT PORTFOLIO
TABLE # 76 PRONOVABIOPHARMA ASA RECENT ACTIVITIES
TABLE # 77 PRONOVABIOPHARMA ASA SWOT ANALYSIS
TABLE # 78 ROYAL DSM N.V. PRODUCT PORTFOLIO
TABLE # 79 ROYAL DSM N.V. RECENT ACTIVITIES
TABLE # 80 ROYAL DSM N.V. SWOT ANALYSIS
TABLE # 81 TASA OMEGA PRODUCT PORTFOLIO
TABLE # 82 TASA OMEGA RECENT ACTIVITIES
TABLE # 83 TASA OMEGA SWOT ANALYSIS
TABLE # 1 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL HOMOGENIZERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL DIETARY SUPPLEMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL FUNCTIONAL FOODS & BEVERAGES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL INFANT FORMULA MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY SOURCE & SUB-SOURCE, 2015-2021, ($ MILLIONS)
TABLE # 10 GLOBAL MARINE SOURCES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 11 GLOBAL FISH OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 12 GLOBAL ALGAL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 13 GLOBAL KRILL OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 14 GLOBAL HEMP OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 15 GLOBAL OTHER MARINE OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 16 GLOBAL PLANT SOURCE MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 17 GLOBAL FLAXSEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 18 GLOBAL CHIA SEED OIL MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 19 GLOBAL OTHER PLANT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 20 GLOBAL OMEGA-3 POLYUNSATURATED FATTY ACID MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 21 GLOBAL DOCOSAHEXAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 22 GLOBAL EICOSAPENTAENOIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 23 GLOBAL ALPHA-LINOLENIC ACID MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 24 AKER BIO MARINE ASA PRODUCT PORTFOLIO
TABLE # 25 AKER BIO MARINE ASA RECENT ACTIVITIES
TABLE # 26 AKER BIO MARINE ASA SWOT ANALYSIS
TABLE # 27 ARISTA INDUSTRIES INC. PRODUCT PORTFOLIO
TABLE # 28 ARISTA INDUSTRIES INC. RECENT ACTIVITIES
TABLE # 29 ARISTA INDUSTRIES INC. SWOT ANALYSIS
TABLE # 30 BASF PRODUCT PORTFOLIO
TABLE # 31 BASF RECENT ACTIVITIES
TABLE # 32 BASF SWOT ANALYSIS
TABLE # 33 CARGILL, INCORPORATED PRODUCT PORTFOLIO
TABLE # 34 CARGILL, INCORPORATED RECENT ACTIVITIES
TABLE # 35 CARGILL, INCORPORATED SWOT ANALYSIS
TABLE # 36 CLOVER CORPORATION PRODUCT PORTFOLIO
TABLE # 37 CLOVER CORPORATION RECENT ACTIVITIES
TABLE # 38 CLOVER CORPORATION SWOT ANALYSIS
TABLE # 39 COPENICA ASA PRODUCT PORTFOLIO
TABLE # 40 COPENICA ASA RECENT ACTIVITIES
TABLE # 41 COPENICA ASA SWOT ANALYSIS
TABLE # 42 CRODA INTERNATIONAL PLC PRODUCT PORTFOLIO
TABLE # 43 CRODA INTERNATIONAL PLC RECENT ACTIVITIES
TABLE # 44 CRODA INTERNATIONAL PLC SWOT ANALYSIS
TABLE # 45 DENEMOGA PRODUCT PORTFOLIO
TABLE # 46 DENEMOGA RECENT ACTIVITIES
TABLE # 47 DENEMOGA SWOT ANALYSIS
TABLE # 48 FMC CORPORATION PRODUCT PORTFOLIO
TABLE # 49 FMC CORPORATION RECENT ACTIVITIES
TABLE # 50 FMC CORPORATION SWOT ANALYSIS
TABLE # 51 GC RIEBER PRODUCT PORTFOLIO
TABLE # 52 GC RIEBER RECENT ACTIVITIES
TABLE # 53 GC RIEBER SWOT ANALYSIS
TABLE # 54 GOLDEN OMEGA S.A. PRODUCT PORTFOLIO
TABLE # 55 GOLDEN OMEGA S.A. RECENT ACTIVITIES
TABLE # 56 GOLDEN OMEGA S.A. SWOT ANALYSIS
TABLE # 57 KD PHARMA BEXBACH GMBH PRODUCT PORTFOLIO
TABLE # 58 KD PHARMA BEXBACH GMBH RECENT ACTIVITIES
TABLE # 59 KD PHARMA BEXBACH GMBH SWOT ANALYSIS
TABLE # 60 MARINE INGREDIENTS LLC. PRODUCT PORTFOLIO
TABLE # 61 MARINE INGREDIENTS LLC. RECENT ACTIVITIES
TABLE # 62 MARINE INGREDIENTS LLC. SWOT ANALYSIS
TABLE # 63 OMEGA PROTEIN CORPORATION PRODUCT PORTFOLIO
TABLE # 64 OMEGA PROTEIN CORPORATION RECENT ACTIVITIES
TABLE # 65 OMEGA PROTEIN CORPORATION SWOT ANALYSIS
TABLE # 66 ORKLA ASA PRODUCT PORTFOLIO
TABLE # 67 ORKLA ASA RECENT ACTIVITIES
TABLE # 68 ORKLA ASA SWOT ANALYSIS
TABLE # 69 PHARMA MARINE USA LLC PRODUCT PORTFOLIO
TABLE # 70 PHARMA MARINE USA LLC RECENT ACTIVITIES
TABLE # 71 PHARMA MARINE USA LLC SWOT ANALYSIS
TABLE # 72 POLARIS PRODUCT PORTFOLIO
TABLE # 73 POLARIS RECENT ACTIVITIES
TABLE # 74 POLARIS SWOT ANALYSIS
TABLE # 75 PRONOVABIOPHARMA ASA PRODUCT PORTFOLIO
TABLE # 76 PRONOVABIOPHARMA ASA RECENT ACTIVITIES
TABLE # 77 PRONOVABIOPHARMA ASA SWOT ANALYSIS
TABLE # 78 ROYAL DSM N.V. PRODUCT PORTFOLIO
TABLE # 79 ROYAL DSM N.V. RECENT ACTIVITIES
TABLE # 80 ROYAL DSM N.V. SWOT ANALYSIS
TABLE # 81 TASA OMEGA PRODUCT PORTFOLIO
TABLE # 82 TASA OMEGA RECENT ACTIVITIES
TABLE # 83 TASA OMEGA SWOT ANALYSIS
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7.1. AKER BIO MARINE ASA
7.2. ARISTA INDUSTRIES INC.
7.3. BASF
7.4. CARGILL, INCORPORATED
7.5. CLOVER CORPORATION
7.6. COPENICA ASA
7.7. CRODA INTERNATIONAL PLC
7.8. DENEMOGA
7.9. FMC CORPORATION
7.10. GC RIEBER
7.11. GOLDEN OMEGA S.A.
7.12. KD PHARMA BEXBACH GMBH
7.13. MARINE INGREDIENTS LLC.
7.14. OMEGA PROTEIN CORPORATION
7.15. ORKLA ASA
7.16. PHARMA MARINE USA LLC
7.17. POLARIS
7.18. PRONOVABIOPHARMA ASA
7.19. ROYAL DSM N.V.
7.20. TASA OMEGA
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7.1. AKER BIO MARINE ASA
7.2. ARISTA INDUSTRIES INC.
7.3. BASF
7.4. CARGILL, INCORPORATED
7.5. CLOVER CORPORATION
7.6. COPENICA ASA
7.7. CRODA INTERNATIONAL PLC
7.8. DENEMOGA
7.9. FMC CORPORATION
7.10. GC RIEBER
7.11. GOLDEN OMEGA S.A.
7.12. KD PHARMA BEXBACH GMBH
7.13. MARINE INGREDIENTS LLC.
7.14. OMEGA PROTEIN CORPORATION
7.15. ORKLA ASA
7.16. PHARMA MARINE USA LLC
7.17. POLARIS
7.18. PRONOVABIOPHARMA ASA
7.19. ROYAL DSM N.V.
7.20. TASA OMEGA
